Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2020 | 09-2020 | 06-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,942,534 | 2,695,300 | 2,231,386 | 2,553,938 | 2,895,713 |
| Marketable Securities | 191,683 | 72,408 | 42,687 | 41,750 | 185,600 |
| Receivables | 3,473,549 | 3,261,772 | 3,504,277 | 3,530,012 | 3,289,140 |
| Inventories | 1,495,133 | 1,463,937 | 1,442,179 | 1,373,339 | 1,376,735 |
| Other current assets | 184,723 | 213,662 | 182,075 | 175,141 | 209,855 |
| TOTAL | $8,287,622 | $7,707,079 | $7,402,604 | $7,674,180 | $7,957,043 |
| Non-Current Assets | |||||
| PPE Net | 2,449,709 | 2,497,298 | 2,484,095 | 2,400,298 | 2,368,775 |
| Investments And Advances | 1,132,838 | 858,154 | 807,854 | 782,800 | 763,688 |
| Intangibles | 9,263,616 | 9,030,589 | 9,358,348 | 6,277,436 | 6,060,837 |
| Other Non-Current Assets | 915,907 | 934,819 | 928,223 | 1,171,256 | 1,261,930 |
| TOTAL | $13,762,070 | $13,320,860 | $13,578,520 | $10,631,790 | $10,455,230 |
| Total Assets | $22,049,690 | $21,027,950 | $20,981,130 | $18,305,970 | $18,412,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,065,600 | 1,067,003 | 1,233,636 | 1,286,675 | 1,491,097 |
| Other current liabilities | 2,963,578 | 2,613,661 | 2,484,932 | 2,439,684 | 2,323,986 |
| TOTAL | $6,104,131 | $5,799,170 | $6,023,350 | $4,287,733 | $4,497,722 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 721,930 | 2,599,147 | 2,612,156 | 693,542 | 1,815,034 |
| TOTAL | $2,806,925 | $2,730,277 | $2,805,605 | $1,897,730 | $1,860,511 |
| Total Liabilities | $8,911,056 | $8,529,457 | $8,828,964 | $6,185,463 | $6,358,233 |
| Shareholders' Equity | |||||
| Common Shares | 988,810 | 968,209 | 957,909 | 947,609 | 957,909 |
| Retained earnings | 9,244,915 | 8,853,361 | 8,545,677 | 8,738,647 | 8,600,072 |
| Other shareholders' equity | 1,268,543 | 1,077,881 | 1,069,772 | 1,193,489 | 900,463 |
| TOTAL | $13,138,650 | $12,498,500 | $12,152,160 | $12,120,500 | $12,054,060 |
| Total Liabilities And Equity | $22,049,706 | $21,027,957 | $20,981,124 | $18,305,963 | $18,412,293 |